Episode
Synthetic cells complete lab cycle & CAR-T strategy for glioblastoma - News (Jul 3, 2026)
- Podcast
- The Automated Daily
- Published
- Jul 3, 2026
- Duration seconds
- 545
- Processing state
not_requested- Canonical source
- https://theautomateddaily.com/episodes/2026-07-03-synthetic-cells-complete-lab-cycle-car-t-strategy-for-glioblastoma
Actions
POST https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/synthetic-cells-complete-lab-cycle-car-t-strategy-for-glioblastoma-news-jul-3-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-automated-daily-6466996/synthetic-cells-complete-lab-cycle-car-t-strategy-for-glioblastoma-news-jul-3-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad - SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Synthetic cells complete lab cycle - University of Minnesota researchers unveiled “SpudCells,” liposome-based synthetic cells that can grow, copy DNA, and divide in a dish—an eye-catching step in bottom-up artificial life research. CAR-T strategy for glioblastoma - A Nature study points to GPNMB-targeting CAR-T cells that may hit both glioblastoma tumor cells and tumor-supporting macrophages, aiming for more durable brain cancer control. GLP-1 drugs and PAD outcomes - An observational TriNetX analysis links GLP-1 receptor agonists like semaglutide with lower death, hospitalization, and amputation risks in people with type 2 diabetes plus peripheral artery disease (PAD), pending randomized trials. Gene therapy sickle cell milestone - Louisiana doctors report a 23-year-old man is functionally cured of sickle cell disease after FDA-approved gene therapy, highlighting expanding real-world access to gene-altering treatments. Supreme Court upholds birthright citizenship - In Trump v. Barbara, the U.S. Supreme Court struck down a 2025 executive order limiting birthright citizenship, reaffirming the 14th Amendment’s long-standing interpretation. UN warns AI governance window closing - A UN scientific panel warns global AI rules are falling behind fast, citing risks from deepfakes, cybercrime, disinformation, and unequal access to comp…